Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine mouthspray and lozenge crossover study in smokers
ACTRN12607000086460Phase 3Recruiting
- Sponsor
- Professor Peter Hajek
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nicotine mouth spray, nicotine and Nicoderm C-Q Gum in nicotine dependence, sponsored by Professor Peter Hajek. Primary endpoint: Change in composite craving score over time. Started Feb 2006; status: recruiting.
02
Drugs
nicotine mouth spraynicotineNicoderm C-Q Gum
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12607000086460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000086460.